Deep knowledge on
small-molecule drugs and
the 90,000 global patents
|Title:||Stable hydrated cephalosporin dry powder for oral suspension formulation|
|Abstract:||A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.|
|Inventor(s):||Johnson; Donald A. (Miami Lakes, FL), Wearley; Lorraine (Westfield, NJ), Galeos; Rebecca (Bloomfield, NJ), Sequeira; Joel A. (New York, NY)|
|Assignee:||Schering Corporation (Kenilworth, NJ)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Formulation; Process; Dosage form;|
|PCT Filed||April 30, 1993||PCT Application Number:||PCT/US93/03856|
|PCT Publication Date:||November 11, 1993||PCT Publication Number:||WO93/21923|
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Russian Federation||94046038||Nov 10, 1996|
|Norway||307594||May 02, 2000|
|European Patent Office||0642344||Mar 15, 1995|
|Australia||674516||Jan 02, 1997|
|Austria||150310||Apr 15, 1997|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.